Search Details

Word: ht (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

Researchers with the Women's Health Initiative (WHI) are adding yet another chapter to the continuing (and confusing) story of hormone therapy (HT) taken during and after menopause. In the latest report, appearing in the Journal of the American Medical Association (JAMA), the study doctors report that the health risks of taking the combined hormones estrogen and progestin can linger for up to three years after women stop taking them...

Author: /time Magazine | Title: Hormone Therapy Risks Linger On | 3/4/2008 | See Source »

...risk of breast cancer, and did not protect women from heart disease, as doctors had previously thought. But the WHI continued to follow these subjects for heart disease, various cancers, stroke, fractures and other causes of death. They found, to their surprise, that the women who had taken HT for three to eight years had a 12% greater risk of overall death than women who had been assigned a placebo pill...

Author: /time Magazine | Title: Hormone Therapy Risks Linger On | 3/4/2008 | See Source »

...While the fact that HT's risks may last longer than any woman would like, doctors stress that this risk is still very small. The overall risk of cancer, for instance, among women taking estrogen and progestin, comes to three extra cases per 1000 women per year. For breast cancer, the study found one extra case per 1000 women per year. "It's helpful to translate the findings into absolute cases," notes Dr. JoAnn Manson, chief of preventive medicine at Harvard's Brigham and Women's Hospital. "So for women who are having distressing menopausal symptoms, who are not sleeping...

Author: /time Magazine | Title: Hormone Therapy Risks Linger On | 3/4/2008 | See Source »

...breast cancer risk associated with the hormones and the lack of heart benefit from the therapy. What this study does is define how long those risks can last. "The results should not be cause for alarm or panic among women," says Manson. "The findings do underscore the point that HT should not be used for chronic disease prevention, but remains a viable option for short-term treatment of menopausal symptoms. When used for the short-term treatment of distressing symptoms, it's likely that the benefits outweigh the risks." As confusing as they seem, taken together, every analysis from...

Author: /time Magazine | Title: Hormone Therapy Risks Linger On | 3/4/2008 | See Source »

...uncertain future, have deep pockets. It should be a perfect match. Yet only a handful of big deals have been inked. For example, Britain's Financial Times has taken a stake in the Business Standard, an Indian business newspaper, and Henderson Global Investments, a British firm, has invested in HT Media. "It's worked out very well for us," says T.N. Ninan, editor of the Business Standard. His paper now carries a daily page of international business news from the Financial Times and frequently runs opinion pieces from the British paper, which help to set it apart from competitors...

Author: /time Magazine | Title: Fishing for the News | 9/19/2005 | See Source »

| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next